SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
27-Sep-24 4:22 PM View: | Bioage Labs, Inc. (BIOA) | 27-Sep-24 | Conversion | 1,638,240 | -- | -- | 100% 0 to 1.64M | |
27-Sep-24 4:22 PM View: | Bioage Labs, Inc. (BIOA) | 27-Sep-24 | Purchase | 666,665 | $18.00 | $12,000,000.00 | 41% 1.64M to 2.3M | |
30-Jul-24 9:05 PM View: | Natera, Inc. (NTRA) | 26-Jul-24 | Grant | 177 | -- | -- | < 1% 1.6M to 1.6M | |
03-Jul-24 8:04 PM View: | Rapport Therapeutics, Inc. (RAPP) | 01-Jul-24 | Purchase | 44,032 | $24.52 | $1,079,580.00 | 2% 1.95M to 2.0M | |
02-Jul-24 9:05 PM View: | Natera, Inc. (NTRA) | 28-Jun-24 | Grant | 2,964 | -- | -- | < 1% 1.59M to 1.6M | |
13-Jun-24 9:01 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 11-Jun-24 | Grant | 3,495 | -- | -- | < 1% 2.22M to 2.23M | |
10-Jun-24 7:38 PM View: | Rapport Therapeutics, Inc. (RAPP) | 10-Jun-24 | Conversion | 1,392,740 | -- | -- | 100% 0 to 1.39M | |
10-Jun-24 7:38 PM View: | Rapport Therapeutics, Inc. (RAPP) | 10-Jun-24 | Purchase | 558,824 | $17.00 | $9,500,010.00 | 40% 1.39M to 1.95M | |
30-Apr-24 8:35 PM View: | Natera, Inc. (NTRA) | 26-Apr-24 | Grant | 210 | -- | -- | < 1% 1.59M to 1.59M | |
18-Mar-24 4:30 PM View: | Karuna Therapeutics, Inc. (KRTX) | 18-Mar-24 | Disposition | 33,490 | $330.00 | $11,051,700.00 | (2%) 1.41M to 1.38M | |
18-Mar-24 4:30 PM View: | Karuna Therapeutics, Inc. (KRTX) | 18-Mar-24 | Disposition | 1,381,150 | $330.00 | $455,779,008.00 | (100%) 1.38M to 0 | |
31-Jan-24 4:10 PM View: | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Conversion | 1,252,310 | -- | -- | 100% 0 to 1.25M | |
31-Jan-24 4:10 PM View: | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Purchase | 444,444 | $18.00 | $7,999,990.00 | 35% 1.25M to 1.7M | |
30-Jan-24 8:05 PM View: | Natera, Inc. (NTRA) | 26-Jan-24 | Grant | 264 | $63.79 | $16,840.60 | < 1% 1.59M to 1.59M | |
22-Dec-23 2:21 PM View: | Natera, Inc. (NTRA) | 13-Dec-23 | Sale | 644,000 | $58.75 | $37,835,000.00 | (29%) 2.24M to 1.59M | |
31-Oct-23 9:05 PM View: | Natera, Inc. (NTRA) | 27-Oct-23 | Grant | 396 | $42.60 | $16,869.60 | < 1% 3.14M to 3.14M | |
01-Aug-23 9:05 PM View: | Natera, Inc. (NTRA) | 28-Jul-23 | Grant | 328 | $48.48 | $15,901.40 | < 1% 3.14M to 3.14M | |
05-Jul-23 10:00 PM View: | Natera, Inc. (NTRA) | 30-Jun-23 | Grant | 2,750 | -- | -- | < 1% 3.14M to 3.14M | |
22-Jun-23 4:16 PM View: | Karuna Therapeutics, Inc. (KRTX) | 20-Jun-23 | Grant | 990 | -- | -- | < 1% 1.41M to 1.41M | |
09-Jun-23 6:00 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 08-Jun-23 | Grant | 2,330 | -- | -- | < 1% 2.22M to 2.22M | |
30-May-23 5:05 PM View: | Natera, Inc. (NTRA) | 25-May-23 | Option Exercise | 3,534 | -- | -- | < 1% 3.14M to 3.14M | |
18-Apr-23 8:10 PM View: | Natera, Inc. (NTRA) | 14-Apr-23 | Grant | 285 | $54.73 | $15,598.00 | < 1% 3.14M to 3.14M | |
27-Feb-23 9:15 PM View: | Cincor Pharma, Inc. (CINC) | 24-Feb-23 | Disposition | 19,608 | -- | -- | (< 1%) 6.1M to 6.08M | |
27-Feb-23 9:15 PM View: | Cincor Pharma, Inc. (CINC) | 24-Feb-23 | Disposition (change in control) | 9,803 | -- | -- | (< 1%) 6.08M to 6.07M | |
27-Feb-23 9:15 PM View: | Cincor Pharma, Inc. (CINC) | 24-Feb-23 | Disposition (change in control) | 6,073,950 | -- | -- | (100%) 6.07M to 0 | |
18-Jan-23 9:35 PM View: | Natera, Inc. (NTRA) | 13-Jan-23 | Grant | 390 | $40.01 | $15,603.90 | < 1% 3.14M to 3.14M | |
17-Jan-23 8:43 PM View: | Karuna Therapeutics, Inc. (KRTX) | 13-Jan-23 | Sale | 6,027 | $199.90 | $1,204,770.00 | (< 1%) 1.81M to 1.81M | |
17-Jan-23 8:43 PM View: | Karuna Therapeutics, Inc. (KRTX) | 12-Jan-23 | Acquisition (other) | 6,027 | -- | -- | < 1% 2.11M to 2.11M | |
17-Jan-23 8:43 PM View: | Karuna Therapeutics, Inc. (KRTX) | 12-Jan-23 | Disposition (other) | 300,000 | -- | -- | (14%) 2.11M to 1.81M | |
27-Feb-23 9:15 PM View: | Cincor Pharma, Inc. (CINC) | 28-Nov-22 | Market Sale | 6,000 | $14.32 | $85,920.00 | (< 1%) 6.11M to 6.1M | 1% |
18-Jan-23 11:12 AM View: | Natera, Inc. (NTRA) | 16-Nov-22 | Sale | 2,400 | $37.71 | $90,498.00 | (< 1%) 3.14M to 3.14M | |
18-Oct-22 9:07 PM View: | Natera, Inc. (NTRA) | 14-Oct-22 | Grant | 344 | $45.42 | $15,624.50 | < 1% 3.14M to 3.14M | |
15-Aug-22 3:45 PM View: | Cincor Pharma, Inc. (CINC) | 11-Aug-22 | Purchase | 506,000 | $30.00 | $15,180,000.00 | 9% 5.6M to 6.11M | |
08-Aug-22 5:43 PM View: | Karuna Therapeutics, Inc. (KRTX) | 05-Aug-22 | Option Exercise | 32,500 | $16.00 | $520,000.00 | 2% 2.07M to 2.11M | |
08-Aug-22 12:57 PM View: | Cincor Pharma, Inc. (CINC) | 05-Aug-22 | Option Exercise | 29,411 | $13.60 | $399,990.00 | < 1% 5.57M to 5.6M | 4% |
01-Jul-22 1:23 PM View: | Karuna Therapeutics, Inc. (KRTX) | 30-Jun-22 | Market Purchase | 72,223 | $122.64 | $8,857,770.00 | 4% 2.0M to 2.07M | 2% |
01-Jul-22 1:23 PM View: | Karuna Therapeutics, Inc. (KRTX) | 29-Jun-22 | Market Purchase | 47,777 | $123.04 | $5,878,390.00 | 2% 1.95M to 2.0M | 2% |
27-May-22 9:46 PM View: | Natera, Inc. (NTRA) | 25-May-22 | Option Exercise | 1,307 | -- | -- | < 1% 3.14M to 3.14M | |
14-Apr-22 4:46 PM View: | Karuna Therapeutics, Inc. (KRTX) | 01-Apr-22 | Market Purchase | 47 | $129.38 | $6,080.86 | < 1% 1.95M to 1.95M | (3%) |
13-Jan-22 4:33 PM View: | Cincor Pharma, Inc. (CINC) | 11-Jan-22 | Conversion | 5,248,950 | -- | -- | 100% 0 to 5.25M | |
13-Jan-22 4:33 PM View: | Cincor Pharma, Inc. (CINC) | 11-Jan-22 | Purchase | 325,000 | $16.00 | $5,200,000.00 | 6% 5.25M to 5.57M | |
29-Sep-21 8:18 PM View: | Coherus Biosciences, Inc. (CHRS) | 29-Sep-21 | Market Sale | 286,076 | $16.12 | $4,611,550.00 | (80%) 356.16K to 70.09K | (5%) |
29-Sep-21 8:18 PM View: | Coherus Biosciences, Inc. (CHRS) | 28-Sep-21 | Market Sale | 48,329 | $17.17 | $829,809.00 | (12%) 404.49K to 356.16K | 2% |
29-Sep-21 8:18 PM View: | Coherus Biosciences, Inc. (CHRS) | 27-Sep-21 | Market Sale | 100,150 | $18.06 | $1,808,710.00 | (20%) 504.64K to 404.49K | 6% |
26-Jul-21 6:11 PM View: | Natera, Inc. (NTRA) | 22-Jul-21 | Market Purchase | 2,400 | $113.00 | $271,200.00 | < 1% 3.13M to 3.14M | < 1% |
07-Jul-21 6:48 PM View: | Karuna Therapeutics, Inc. (KRTX) | 02-Jul-21 | Market Purchase | 636 | $117.80 | $74,923.10 | 100% 0 to 0.64K | 15% |
02-Jun-21 8:05 PM View: | Natera, Inc. (NTRA) | 28-May-21 | Option Exercise | 2,856 | -- | -- | < 1% 3.13M to 3.13M | |
09-Feb-21 3:29 PM View: | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Conversion Duplicate | 2,304,440 | -- | -- | 100% 2.3M to 4.61M | |
09-Feb-21 3:29 PM View: | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase Duplicate | 450,000 | $20.00 | $9,000,000.00 | 10% 4.61M to 5.06M | |
01-Oct-20 4:54 PM View: | Coherus Biosciences, Inc. (CHRS) | 29-Sep-20 | Acquisition (other) | 213,546 | -- | -- | 17% 1.24M to 1.45M |